AU2001258662A1 - Use of a lacrophyl preparation in eye-drops containing therapeutically active compounds - Google Patents
Use of a lacrophyl preparation in eye-drops containing therapeutically active compoundsInfo
- Publication number
- AU2001258662A1 AU2001258662A1 AU2001258662A AU5866201A AU2001258662A1 AU 2001258662 A1 AU2001258662 A1 AU 2001258662A1 AU 2001258662 A AU2001258662 A AU 2001258662A AU 5866201 A AU5866201 A AU 5866201A AU 2001258662 A1 AU2001258662 A1 AU 2001258662A1
- Authority
- AU
- Australia
- Prior art keywords
- eye
- lacrophyl
- active substance
- active compounds
- therapeutically active
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 239000003889 eye drop Substances 0.000 title abstract 3
- 229940012356 eye drops Drugs 0.000 title abstract 3
- 238000002360 preparation method Methods 0.000 title abstract 2
- 150000001875 compounds Chemical class 0.000 title 1
- 239000013543 active substance Substances 0.000 abstract 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 abstract 3
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 abstract 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 2
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 abstract 1
- 102000016943 Muramidase Human genes 0.000 abstract 1
- 108010014251 Muramidase Proteins 0.000 abstract 1
- 108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 abstract 1
- 235000010323 ascorbic acid Nutrition 0.000 abstract 1
- 229960005070 ascorbic acid Drugs 0.000 abstract 1
- 239000011668 ascorbic acid Substances 0.000 abstract 1
- 238000004090 dissolution Methods 0.000 abstract 1
- 239000012153 distilled water Substances 0.000 abstract 1
- 229960001484 edetic acid Drugs 0.000 abstract 1
- 235000010335 lysozyme Nutrition 0.000 abstract 1
- 229960000274 lysozyme Drugs 0.000 abstract 1
- 239000004325 lysozyme Substances 0.000 abstract 1
- 230000002906 microbiologic effect Effects 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 239000002504 physiological saline solution Substances 0.000 abstract 1
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/46—Ingredients of undetermined constitution or reaction products thereof, e.g. skin, bone, milk, cotton fibre, eggshell, oxgall or plant extracts
Landscapes
- Health & Medical Sciences (AREA)
- Ophthalmology & Optometry (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| HU0001769 | 2000-05-04 | ||
| HU0001769A HUP0001769A2 (hu) | 2000-05-04 | 2000-05-04 | Lakrofil készítmény alkalmazása gyógyászati hatóanyag-tartalmú szemcseppekben |
| PCT/HU2001/000053 WO2001082893A1 (en) | 2000-05-04 | 2001-05-04 | Use of a lacrophyl preparation in eye-drops containing therapeutically active compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU2001258662A1 true AU2001258662A1 (en) | 2001-11-12 |
Family
ID=89978306
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2001258662A Abandoned AU2001258662A1 (en) | 2000-05-04 | 2001-05-04 | Use of a lacrophyl preparation in eye-drops containing therapeutically active compounds |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US6949241B2 (de) |
| EP (1) | EP1278511B1 (de) |
| AT (1) | ATE272389T1 (de) |
| AU (1) | AU2001258662A1 (de) |
| CA (1) | CA2407794A1 (de) |
| DE (1) | DE60104670T2 (de) |
| ES (1) | ES2248326T3 (de) |
| HU (1) | HUP0001769A2 (de) |
| WO (1) | WO2001082893A1 (de) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20040229814A1 (en) * | 2002-08-28 | 2004-11-18 | James Dillon | Methods and compositions for protecting against cataract development associated with vitrectomies |
| US7220422B2 (en) * | 2003-05-20 | 2007-05-22 | Allergan, Inc. | Methods and compositions for treating eye disorders |
| US20060275278A1 (en) * | 2005-06-02 | 2006-12-07 | Choy Camus K M | Method and ophthalmic formulation for eye protection or treatment |
| EP2035015A4 (de) * | 2006-05-01 | 2009-11-11 | Riolan Technologies Inc | Zusammensetzungen, verfahren und kits zur behandlung des trockenen auges |
| EP2134355A4 (de) * | 2007-03-02 | 2012-01-11 | Saint Simeon Lda | Neue ophthalmische zusammensetzungen mit humanem rekombinantem lysozym und ihre verwendung zur behandlung von augenerkrankungen und als kontaktlinsenlösungen |
| CN103182075B (zh) * | 2011-12-30 | 2015-07-22 | 沈阳兴齐眼药股份有限公司 | 一种溶菌酶制剂、其制备方法及用途 |
| US20170202850A1 (en) * | 2014-07-21 | 2017-07-20 | Hiroaki Serizawa | Ophthalmic compositions of rifamycins and uses thereof |
| WO2016077457A1 (en) | 2014-11-11 | 2016-05-19 | Clara Foods Co. | Methods and compositions for egg white protein production |
| WO2017209721A1 (en) | 2016-06-02 | 2017-12-07 | Alemdar Eda | A drug derived from enzymes present in the human saliva for use in preventing corneal clouding or cataract formation |
| MX2022000374A (es) | 2019-07-11 | 2022-03-25 | Clara Foods Co | Composiciones de proteina y productos consumibles de las mismas. |
| US10927360B1 (en) | 2019-08-07 | 2021-02-23 | Clara Foods Co. | Compositions comprising digestive enzymes |
| JPWO2022138639A1 (de) * | 2020-12-21 | 2022-06-30 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5188826A (en) * | 1988-02-08 | 1993-02-23 | Insite Vision Incorporated | Topical ophthalmic suspensions |
| US5192535A (en) * | 1988-02-08 | 1993-03-09 | Insite Vision Incorporated | Ophthalmic suspensions |
| HU209538B (en) * | 1990-05-09 | 1994-07-28 | Vepex Contractor Ltd | Set and cleaning composition for treating contactlenses |
-
2000
- 2000-05-04 HU HU0001769A patent/HUP0001769A2/hu unknown
-
2001
- 2001-05-04 US US10/275,125 patent/US6949241B2/en not_active Expired - Fee Related
- 2001-05-04 DE DE2001604670 patent/DE60104670T2/de not_active Expired - Lifetime
- 2001-05-04 CA CA002407794A patent/CA2407794A1/en not_active Abandoned
- 2001-05-04 ES ES01931980T patent/ES2248326T3/es not_active Expired - Lifetime
- 2001-05-04 AT AT01931980T patent/ATE272389T1/de not_active IP Right Cessation
- 2001-05-04 AU AU2001258662A patent/AU2001258662A1/en not_active Abandoned
- 2001-05-04 WO PCT/HU2001/000053 patent/WO2001082893A1/en active IP Right Grant
- 2001-05-04 EP EP01931980A patent/EP1278511B1/de not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| US20030124112A1 (en) | 2003-07-03 |
| DE60104670T2 (de) | 2005-01-13 |
| HU0001769D0 (en) | 2000-07-28 |
| ATE272389T1 (de) | 2004-08-15 |
| ES2248326T3 (es) | 2006-03-16 |
| DE60104670D1 (de) | 2004-09-09 |
| US6949241B2 (en) | 2005-09-27 |
| EP1278511B1 (de) | 2004-08-04 |
| CA2407794A1 (en) | 2001-11-08 |
| WO2001082893A1 (en) | 2001-11-08 |
| HUP0001769A2 (hu) | 2002-01-28 |
| EP1278511A1 (de) | 2003-01-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2525401A (en) | Use of an extract of at least one vaccinium-type plant as an anti-glycation agent | |
| AU2001258662A1 (en) | Use of a lacrophyl preparation in eye-drops containing therapeutically active compounds | |
| EP0993831A3 (de) | Komponente und Zusammensetzungen zur Verabreichung von Wirkstoffen | |
| AU4711296A (en) | Method for loading lipid vesicles | |
| DE69942154D1 (de) | Medikamenthaltige zusammensetzung in aerosolform | |
| ATE311227T1 (de) | Schnell-wirkende, gefrier-trocknete, orale, pharmazeutische formulierung für die behandlung von migräne | |
| WO2000040203A3 (en) | Polymeric delivery agents and delivery agent compounds | |
| DK1283700T3 (da) | Farmaceutiske sustained release-præparater til parenteral administration af biologisk aktive hydrofile forbindelser | |
| WO2003068144A3 (en) | Cytotoxic agents | |
| AU2845599A (en) | Pharmaceutical compositions and their use | |
| WO2000007979A3 (en) | Compounds and compositions for delivering active agents | |
| AU2001296865A1 (en) | (5-(2-hydroxy-4-chlorobenzoyl) aminovaleric acid and salts thereof and compositions containing the same for delivering active agents | |
| AU3956599A (en) | Surfactant for use in external preparations for skin and external preparation for skin containing the same | |
| EP1003526A4 (de) | Kovalent gebundenes n,o-carboxymethylchitosan und seine verwendung | |
| TR199801861T2 (xx) | Farmas�tik olarak yararl� bile�imler. | |
| AU2002214389A1 (en) | Pharmaceutical composition containing honey for the treatment of wounds | |
| WO2002043706A3 (en) | Prolamin-based sustained-release compositions and delayed-onset compositions | |
| AU2001289714A1 (en) | Benzofuran derivatives and their use as antibacterial agents | |
| AU2001267561A1 (en) | Combination preparations of 3-n-formylhydroxylaminopropyl phosphonic acid derivatives or 3-n-acetylhydroxylaminopropyl phosphonic acid derivatives combined withspecific pharmaceutical active agents | |
| ATE234096T1 (de) | Pharmazeutische zusammensetzung zur systemischen transdermalen verabreichung mit dem wirkstoff morphin-6-glucuronid | |
| ES2188021T3 (es) | Metodo para evitar el uso indebido de un sistema terapeutico percutaneo. | |
| CA2395438A1 (en) | Dry compositions containing hydrophobic amino acid | |
| ATE211489T1 (de) | Chitosan enthaltende zusammensetzung | |
| SE9803107D0 (sv) | Novel Compunds | |
| IE890275L (en) | Pharmaceutical composition for 4-aroylimidazol-2-ones |